Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range

In no other area of aesthetics are there so many different products or treatment options available as dermal fillers. Along with botulinum toxin injections, fillers are the bread and butter of most medical aesthetic clinics, with their popularity soaring as public awareness and acceptance of non-surgical enhancement grows. In recent years fillers have also become more than just a treatment for lines and wrinkles with advanced indications including lip enhancement, cheek and chin augmentation, and nose re-shaping to name a few.  Despite the variety of injectable fillers available internationally, continuing to grow endlessly, Hyaluronic Acid fillers still remain by far the most popular dermal fillers with both injecting doctors and patients alike.

Global dermatology company Galderma, recently launched their latest Hyaluronic Acid based filler range called Emervel in Malta. As a leader in medical dermatological solutions, Galderma always strives to innovate, offering physicians more options, and patientssuperior and safer results. With Restylane, the first Hyaluronic Acid range of fillerscreated over 15 years ago, Galderma has set the industry’s gold standard for dermal fillers.

To introduce the Emervel range in Malta and to continue updating local Restylane injectors with the latest techniques, Galderma in collaboration with its local agent Prohealth, invited the internationally renowned Plastic Reconstructive & Aesthetic Surgeon Mr. Carlo Di Gregorio to Malta to conduct a training workshop. Mr. De Gregorio obtained a fellowship in plastic surgery in Canniesburn, Scotland and has had extensive professional experiences in Italy, France and the USA. He is a member of the SICPRE and of the International Expert Panel on Hyaluronic Acid.  His publications include medical book chapters, invited reviews, and numerous articles, national and international presentations.

The workshop was held at Persona Med-Aesthetic Centre in Ta’ Xbiex over a 2 day period last week. Local injector doctors and leading plastic surgeons wereprovided with in-depth product training accompanied by key insights into the latest techniques used when injecting Hyaluronic Acid based fillers for rejuvenating, hydrating, and corrective purposes. Great emphasis was made on the importance of a “natural look” approach and outcome at all times. The attendees enjoyed the experiences shared and witnessed the latest techniques for impressive lifting and filling capacity of Restylane Perlane (the No 1 used filler in the world) and the fresh, radiant look achieved thanks to the deep hydration of the increasingly popular SkinBoosters range. The new Emervel Hyaluronic Acid based provide soft, subtle results andexcellent alternatives for Lip and Cheek Augmentation.

Restylane, Emervel, and Restylane SkinBoosters all subscribe to the philosophy of creating natural looking results. As part of this philosophy, Galderma recently launched a new campaign called Proof in Real Life, with the aim of challenging misconceptions that aesthetic treatments create extreme results by proving the subtle results in real life.

This event was hosted by beauty and entertainment icon Sharon Stone last May in Berlin. Sharon Stone, well-known and admired world-wide for her beauty & natural looks, is the first celebrity to endorse an aesthetic brand to increase openness and understanding of aesthetic treatments, and the natural-looking results they can create. ‘So many people are put off by aesthetic treatments because of extreme images, and the Proof in Real Life campaign has provided results people have been able to see first-hand, giving them an opportunity to judge for themselves’ said the actress during the event.

The Galderma Proof in Real Life campaign launch event saw ten sets of identical twins take part in a unique challenge. One twin from each pair received a bespoke treatment plan, which consisted of treatments with Restylane fillers, Restylane Skinboosters, or a combination of both. The twins took part in a live reveal to demonstrate the natural-looking results first-hand and challenge the wide-spread misconception that aesthetic treatments create extreme results. Coverage, including videos and images of the event are available at www.proofirl.com.

Restylane, Emervel and Restylane SkinBoosters treatments can be performed at leading plastic surgeons, and other injecting doctors, as well as at Persona Med-Aesthetic Centre.For details of the doctors offering Restylane, Emervel and Restylane Skinboosters treatments please email restylane@prohealth.com.mt

Source: http://www.independent.com.mt/  back

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more